BeStock  
Markets › Compare › TEVA vs HLN

TEVA vs HLN

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
TEVA · Teva Pharmaceutical Industries$39.27 ▼ 0.85%
HLN · Haleon$8.74 ▼ 2.89%

Head to head

MetricTEVAHLN
Price$39.27$8.74
Change today▼ 0.85%▼ 2.89%
Market cap$45.79B$38.44B
Return, 3 months––
Return, year to date––
Return, 1 year––
P/E (TTM)65.418.2
P/B5.91.8
P/E percentile vs own 5y100th10th
Dividend yield–2.17%
Revenue growth (YoY, latest qtr)-0.8%-0.3%
Net profit growth (YoY)-303.2%+3,071.4%
Gross margin52.5%65.0%
Operating margin18.7%21.4%
Net margin4.1%14.6%
Return on equity9.7%10.0%
Analyst target vs. price+14.6%+25.9%
Analyst buy share100%100%
RSI (14)––
30-day volatility––
Max drawdown, 1 year––
Trend read––
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • TEVA is the largest of the group by market value.
  • HLN carries the lowest trailing P/E.
  • HLN is growing revenue fastest.
  • HLN keeps the most profit per dollar of sales.

Go deeper

Scroll to Top